Company Profile
Sutro Biopharma Stock Price, News & Analysis
- Ticker:
- STRO
- Exchange:
- NASDAQ
- Sector:
- Biotechnology
- Location:
- Headquartered in the United States and listed on NASDAQ, Sutro Biopharma is followed within the biopharmaceutical universe for its exposure to pipeline and commercialization catalysts.
Stock performance
29.19 USD (-7.48%)
Close
Last updated: June 23, 2026 at 00:00
483.69M USD
Market cap
Why the stock is moving
STRO is trading with a steady catalyst profile while investors wait for the next headline that changes the story.
Company overview
Business overview
Sutro Biopharma is a biopharmaceutical company focused on pipeline execution and catalyst-driven growth, with investors tracking how data, regulatory milestones, and launch timing reshape the investment case.
Geographic Base and Sector Classification
Headquartered in the United States and listed on NASDAQ, Sutro Biopharma is followed within the biopharmaceutical universe for its exposure to pipeline and commercialization catalysts.
Business Model Characteristics
Sutro Biopharma follows a pipeline-led model where clinical readouts, filing updates, and program expansion determine how the market underwrites the story.
Position Within the Biotechnology Landscape
Compared with more mature healthcare names, Sutro Biopharma sits on the development side of the biotech landscape, where catalyst timing can reprice the stock quickly.
Future catalysts
Recent news
The five most recent feed items are shown below in reverse chronological order.
Similar stocks
Peer names with similar commercial maturity, therapeutic overlap, or catalyst patterns.
Frequently Asked Questions
What is the current stock price of Sutro Biopharma (STRO)?
Sutro Biopharma (STRO) most recently closed at 29.19 USD, a -7.48% move versus the previous session.
What is the market cap of Sutro Biopharma (STRO)?
Sutro Biopharma currently has a market capitalization of 483.69M USD on BioPharmSignal.
What does Sutro Biopharma do?
Sutro Biopharma is a biopharmaceutical company focused on pipeline execution and catalyst-driven growth, with investors tracking how data, regulatory milestones, and launch timing reshape the investment case.
On which exchange is STRO stock listed?
Sutro Biopharma (STRO) is associated with NASDAQ, Headquartered in the United States and listed on NASDAQ, Sutro Biopharma is followed within the biopharmaceutical universe for its exposure to pipeline and commercialization catalysts., Biotechnology.
What is Sutro?
Sutro Biopharma is a biopharmaceutical company focused on pipeline execution and catalyst-driven growth, with investors tracking how data, regulatory milestones, and launch timing reshape the investment case.
Which conditions is Sutro Biopharma targeting with Sutro?
Sutro Biopharma is a biopharmaceutical company focused on pipeline execution and catalyst-driven growth, with investors tracking how data, regulatory milestones, and launch timing reshape the investment case.
What is Biopharma?
Sutro Biopharma is a biopharmaceutical company focused on pipeline execution and catalyst-driven growth, with investors tracking how data, regulatory milestones, and launch timing reshape the investment case.